An essential source of information and analysis on the global angina pectoris market. The report identifies the key trends shaping and driving the global angina pectoris market, a key segment within the pharma industry.

The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global angina pectoris sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by our team of industry experts.


Scope

The scope of the report includes:

- Annualized global angina pectoris market revenue data from 2001 to 2009, forecast forward 7 years to 2016.

- Geographies covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France, and Japan.

- Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. Key classes of mechanism of action includes gene therapy, combinational therapies, nitric oxide targettors, beta-1 adrenergic receptor antagonists, stem cell therapy, enzyme inhibitors, immunologic drugs, coagulation factor Xa inhibitors, adenosine A1 agonists, anticoagulants and calcium/potassium and sodium channel blockers.

- Analysis of the current and future market competition in the global angina pectoris market. The key market players covered are Solvay Pharmaceuticals, Cardium Therapeutics, Inc., Bayer Healthcare AG., Atherogenics, Inc., Cytokinetics, Inc, Arca Biopharma, Inc., Anthera Pharmaceuticals, Inc, Lacer S.A and Circ Pharma.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with angina pectoris


Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global angina pectoris market.

- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global angina pectoris market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What’s the next big thing in the global angina pectoris market landscape? – Identify, understand and capitalize.

Table of Contents



72 pages

Publication Date : January 2010